+1 (704) 266-3234
+1 (704) 266-3234You are here :
Published on: Jan 2024 | From USD $3660 | Published By: LP INFORMATION INC | Number Of Pages: 107
According to our LPI (LP Information) latest study, the global Next Generation Antibody Therapeutics market size was valued at US$ 9392.2 million in 2023. With growing demand in downstream market, the Next Generation Antibody Therapeutics is forecast to a readjusted size of US$ 38470 million by 2030 with a CAGR of 22.3% during review period.
The research report highlights the growth potential of the global Next Generation Antibody Therapeutics market. Next Generation Antibody Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Next Generation Antibody Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Next Generation Antibody Therapeutics market.
Building on the huge success of monoclonal antibody therapeutics, the next generation of antibody-based products such as Antibody Drug Conjugate (ADC) and Bispecific Antibody (BsAb) is now opening up new opportunities.
Global key players of next generation antibody therapeutics include Roche, Seagen, Amgen, Pfizer, Takeda, etc. The top two players hold a share over 70%. North America is the largest market, has a share about 65%, followed by Europe and Asia-Pacific, with share 16% and 15%, separately. In terms of product type, Antibody Drug Conjugate (ADC) is the largest segment, occupied for a share of 60%, and in terms of application, Cancer has a share about 66 percent.
Key Features:
The report on Next Generation Antibody Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Next Generation Antibody Therapeutics market. It may include historical data, market segmentation by Type (e.g., Antibody Drug Conjugate (ADC), Bispecific Antibody (BsAb)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Next Generation Antibody Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Next Generation Antibody Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Next Generation Antibody Therapeutics industry. This include advancements in Next Generation Antibody Therapeutics technology, Next Generation Antibody Therapeutics new entrants, Next Generation Antibody Therapeutics new investment, and other innovations that are shaping the future of Next Generation Antibody Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Next Generation Antibody Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Next Generation Antibody Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Next Generation Antibody Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Next Generation Antibody Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Next Generation Antibody Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Next Generation Antibody Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Next Generation Antibody Therapeutics market.
Market Segmentation:
Next Generation Antibody Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Antibody Drug Conjugate (ADC)
Bispecific Antibody (BsAb)
Segmentation by application
Cancer
Haemophilia
Other Non-Cancer Diseases
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche
Amgen
Pfizer
Takeda
Daiichi Sankyo
Seagen
Astellas
Immunomedics
GSK
Immunocore
ADC Therapeutics
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Next Generation Antibody Therapeutics Market Size 2019-2030
2.1.2 Next Generation Antibody Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Next Generation Antibody Therapeutics Segment by Type
2.2.1 Antibody Drug Conjugate (ADC)
2.2.2 Bispecific Antibody (BsAb)
2.3 Next Generation Antibody Therapeutics Market Size by Type
2.3.1 Next Generation Antibody Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Next Generation Antibody Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Next Generation Antibody Therapeutics Segment by Application
2.4.1 Cancer
2.4.2 Haemophilia
2.4.3 Other Non-Cancer Diseases
2.5 Next Generation Antibody Therapeutics Market Size by Application
2.5.1 Next Generation Antibody Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Next Generation Antibody Therapeutics Market Size Market Share by Application (2019-2024)
3 Next Generation Antibody Therapeutics Market Size by Player
3.1 Next Generation Antibody Therapeutics Market Size Market Share by Players
3.1.1 Global Next Generation Antibody Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Next Generation Antibody Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Next Generation Antibody Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Next Generation Antibody Therapeutics by Regions
4.1 Next Generation Antibody Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Next Generation Antibody Therapeutics Market Size Growth (2019-2024)
4.3 APAC Next Generation Antibody Therapeutics Market Size Growth (2019-2024)
4.4 Europe Next Generation Antibody Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Next Generation Antibody Therapeutics Market Size Growth (2019-2024)
5 Americas
5.1 Americas Next Generation Antibody Therapeutics Market Size by Country (2019-2024)
5.2 Americas Next Generation Antibody Therapeutics Market Size by Type (2019-2024)
5.3 Americas Next Generation Antibody Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Next Generation Antibody Therapeutics Market Size by Region (2019-2024)
6.2 APAC Next Generation Antibody Therapeutics Market Size by Type (2019-2024)
6.3 APAC Next Generation Antibody Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Next Generation Antibody Therapeutics by Country (2019-2024)
7.2 Europe Next Generation Antibody Therapeutics Market Size by Type (2019-2024)
7.3 Europe Next Generation Antibody Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Next Generation Antibody Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Next Generation Antibody Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Next Generation Antibody Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Next Generation Antibody Therapeutics Market Forecast
10.1 Global Next Generation Antibody Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Next Generation Antibody Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Next Generation Antibody Therapeutics Forecast
10.1.3 APAC Next Generation Antibody Therapeutics Forecast
10.1.4 Europe Next Generation Antibody Therapeutics Forecast
10.1.5 Middle East & Africa Next Generation Antibody Therapeutics Forecast
10.2 Americas Next Generation Antibody Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Next Generation Antibody Therapeutics Market Forecast
10.2.2 Canada Next Generation Antibody Therapeutics Market Forecast
10.2.3 Mexico Next Generation Antibody Therapeutics Market Forecast
10.2.4 Brazil Next Generation Antibody Therapeutics Market Forecast
10.3 APAC Next Generation Antibody Therapeutics Forecast by Region (2025-2030)
10.3.1 China Next Generation Antibody Therapeutics Market Forecast
10.3.2 Japan Next Generation Antibody Therapeutics Market Forecast
10.3.3 Korea Next Generation Antibody Therapeutics Market Forecast
10.3.4 Southeast Asia Next Generation Antibody Therapeutics Market Forecast
10.3.5 India Next Generation Antibody Therapeutics Market Forecast
10.3.6 Australia Next Generation Antibody Therapeutics Market Forecast
10.4 Europe Next Generation Antibody Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Next Generation Antibody Therapeutics Market Forecast
10.4.2 France Next Generation Antibody Therapeutics Market Forecast
10.4.3 UK Next Generation Antibody Therapeutics Market Forecast
10.4.4 Italy Next Generation Antibody Therapeutics Market Forecast
10.4.5 Russia Next Generation Antibody Therapeutics Market Forecast
10.5 Middle East & Africa Next Generation Antibody Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Next Generation Antibody Therapeutics Market Forecast
10.5.2 South Africa Next Generation Antibody Therapeutics Market Forecast
10.5.3 Israel Next Generation Antibody Therapeutics Market Forecast
10.5.4 Turkey Next Generation Antibody Therapeutics Market Forecast
10.5.5 GCC Countries Next Generation Antibody Therapeutics Market Forecast
10.6 Global Next Generation Antibody Therapeutics Forecast by Type (2025-2030)
10.7 Global Next Generation Antibody Therapeutics Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Next Generation Antibody Therapeutics Product Offered
11.1.3 Roche Next Generation Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Amgen
11.2.1 Amgen Company Information
11.2.2 Amgen Next Generation Antibody Therapeutics Product Offered
11.2.3 Amgen Next Generation Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Amgen Main Business Overview
11.2.5 Amgen Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Next Generation Antibody Therapeutics Product Offered
11.3.3 Pfizer Next Generation Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Takeda
11.4.1 Takeda Company Information
11.4.2 Takeda Next Generation Antibody Therapeutics Product Offered
11.4.3 Takeda Next Generation Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Takeda Main Business Overview
11.4.5 Takeda Latest Developments
11.5 Daiichi Sankyo
11.5.1 Daiichi Sankyo Company Information
11.5.2 Daiichi Sankyo Next Generation Antibody Therapeutics Product Offered
11.5.3 Daiichi Sankyo Next Generation Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Daiichi Sankyo Main Business Overview
11.5.5 Daiichi Sankyo Latest Developments
11.6 Seagen
11.6.1 Seagen Company Information
11.6.2 Seagen Next Generation Antibody Therapeutics Product Offered
11.6.3 Seagen Next Generation Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Seagen Main Business Overview
11.6.5 Seagen Latest Developments
11.7 Astellas
11.7.1 Astellas Company Information
11.7.2 Astellas Next Generation Antibody Therapeutics Product Offered
11.7.3 Astellas Next Generation Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Astellas Main Business Overview
11.7.5 Astellas Latest Developments
11.8 Immunomedics
11.8.1 Immunomedics Company Information
11.8.2 Immunomedics Next Generation Antibody Therapeutics Product Offered
11.8.3 Immunomedics Next Generation Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Immunomedics Main Business Overview
11.8.5 Immunomedics Latest Developments
11.9 GSK
11.9.1 GSK Company Information
11.9.2 GSK Next Generation Antibody Therapeutics Product Offered
11.9.3 GSK Next Generation Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 GSK Main Business Overview
11.9.5 GSK Latest Developments
11.10 Immunocore
11.10.1 Immunocore Company Information
11.10.2 Immunocore Next Generation Antibody Therapeutics Product Offered
11.10.3 Immunocore Next Generation Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Immunocore Main Business Overview
11.10.5 Immunocore Latest Developments
11.11 ADC Therapeutics
11.11.1 ADC Therapeutics Company Information
11.11.2 ADC Therapeutics Next Generation Antibody Therapeutics Product Offered
11.11.3 ADC Therapeutics Next Generation Antibody Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 ADC Therapeutics Main Business Overview
11.11.5 ADC Therapeutics Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Next Generation Antibody Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Antibody Drug Conjugate (ADC)
Table 3. Major Players of Bispecific Antibody (BsAb)
Table 4. Next Generation Antibody Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Next Generation Antibody Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Next Generation Antibody Therapeutics Market Size Market Share by Type (2019-2024)
Table 7. Next Generation Antibody Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Next Generation Antibody Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Next Generation Antibody Therapeutics Market Size Market Share by Application (2019-2024)
Table 10. Global Next Generation Antibody Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Next Generation Antibody Therapeutics Revenue Market Share by Player (2019-2024)
Table 12. Next Generation Antibody Therapeutics Key Players Head office and Products Offered
Table 13. Next Generation Antibody Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Next Generation Antibody Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Next Generation Antibody Therapeutics Market Size Market Share by Regions (2019-2024)
Table 18. Global Next Generation Antibody Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Next Generation Antibody Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Next Generation Antibody Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Next Generation Antibody Therapeutics Market Size Market Share by Country (2019-2024)
Table 22. Americas Next Generation Antibody Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Next Generation Antibody Therapeutics Market Size Market Share by Type (2019-2024)
Table 24. Americas Next Generation Antibody Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Next Generation Antibody Therapeutics Market Size Market Share by Application (2019-2024)
Table 26. APAC Next Generation Antibody Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Next Generation Antibody Therapeutics Market Size Market Share by Region (2019-2024)
Table 28. APAC Next Generation Antibody Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Next Generation Antibody Therapeutics Market Size Market Share by Type (2019-2024)
Table 30. APAC Next Generation Antibody Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Next Generation Antibody Therapeutics Market Size Market Share by Application (2019-2024)
Table 32. Europe Next Generation Antibody Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Next Generation Antibody Therapeutics Market Size Market Share by Country (2019-2024)
Table 34. Europe Next Generation Antibody Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Next Generation Antibody Therapeutics Market Size Market Share by Type (2019-2024)
Table 36. Europe Next Generation Antibody Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Next Generation Antibody Therapeutics Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Next Generation Antibody Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Next Generation Antibody Therapeutics Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Next Generation Antibody Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Next Generation Antibody Therapeutics Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Next Generation Antibody Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Next Generation Antibody Therapeutics Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Next Generation Antibody Therapeutics
Table 45. Key Market Challenges & Risks of Next Generation Antibody Therapeutics
Table 46. Key Industry Trends of Next Generation Antibody Therapeutics
Table 47. Global Next Generation Antibody Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Next Generation Antibody Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Next Generation Antibody Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Next Generation Antibody Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Roche Details, Company Type, Next Generation Antibody Therapeutics Area Served and Its Competitors
Table 52. Roche Next Generation Antibody Therapeutics Product Offered
Table 53. Roche Next Generation Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Roche Main Business
Table 55. Roche Latest Developments
Table 56. Amgen Details, Company Type, Next Generation Antibody Therapeutics Area Served and Its Competitors
Table 57. Amgen Next Generation Antibody Therapeutics Product Offered
Table 58. Amgen Main Business
Table 59. Amgen Next Generation Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Amgen Latest Developments
Table 61. Pfizer Details, Company Type, Next Generation Antibody Therapeutics Area Served and Its Competitors
Table 62. Pfizer Next Generation Antibody Therapeutics Product Offered
Table 63. Pfizer Main Business
Table 64. Pfizer Next Generation Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Pfizer Latest Developments
Table 66. Takeda Details, Company Type, Next Generation Antibody Therapeutics Area Served and Its Competitors
Table 67. Takeda Next Generation Antibody Therapeutics Product Offered
Table 68. Takeda Main Business
Table 69. Takeda Next Generation Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Takeda Latest Developments
Table 71. Daiichi Sankyo Details, Company Type, Next Generation Antibody Therapeutics Area Served and Its Competitors
Table 72. Daiichi Sankyo Next Generation Antibody Therapeutics Product Offered
Table 73. Daiichi Sankyo Main Business
Table 74. Daiichi Sankyo Next Generation Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Daiichi Sankyo Latest Developments
Table 76. Seagen Details, Company Type, Next Generation Antibody Therapeutics Area Served and Its Competitors
Table 77. Seagen Next Generation Antibody Therapeutics Product Offered
Table 78. Seagen Main Business
Table 79. Seagen Next Generation Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Seagen Latest Developments
Table 81. Astellas Details, Company Type, Next Generation Antibody Therapeutics Area Served and Its Competitors
Table 82. Astellas Next Generation Antibody Therapeutics Product Offered
Table 83. Astellas Main Business
Table 84. Astellas Next Generation Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Astellas Latest Developments
Table 86. Immunomedics Details, Company Type, Next Generation Antibody Therapeutics Area Served and Its Competitors
Table 87. Immunomedics Next Generation Antibody Therapeutics Product Offered
Table 88. Immunomedics Main Business
Table 89. Immunomedics Next Generation Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Immunomedics Latest Developments
Table 91. GSK Details, Company Type, Next Generation Antibody Therapeutics Area Served and Its Competitors
Table 92. GSK Next Generation Antibody Therapeutics Product Offered
Table 93. GSK Main Business
Table 94. GSK Next Generation Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. GSK Latest Developments
Table 96. Immunocore Details, Company Type, Next Generation Antibody Therapeutics Area Served and Its Competitors
Table 97. Immunocore Next Generation Antibody Therapeutics Product Offered
Table 98. Immunocore Main Business
Table 99. Immunocore Next Generation Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Immunocore Latest Developments
Table 101. ADC Therapeutics Details, Company Type, Next Generation Antibody Therapeutics Area Served and Its Competitors
Table 102. ADC Therapeutics Next Generation Antibody Therapeutics Product Offered
Table 103. ADC Therapeutics Next Generation Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. ADC Therapeutics Main Business
Table 105. ADC Therapeutics Latest Developments
List of Figures
Figure 1. Next Generation Antibody Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Next Generation Antibody Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Next Generation Antibody Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Next Generation Antibody Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Next Generation Antibody Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Next Generation Antibody Therapeutics Market Size Market Share by Type in 2023
Figure 10. Next Generation Antibody Therapeutics in Cancer
Figure 11. Global Next Generation Antibody Therapeutics Market: Cancer (2019-2024) & ($ Millions)
Figure 12. Next Generation Antibody Therapeutics in Haemophilia
Figure 13. Global Next Generation Antibody Therapeutics Market: Haemophilia (2019-2024) & ($ Millions)
Figure 14. Next Generation Antibody Therapeutics in Other Non-Cancer Diseases
Figure 15. Global Next Generation Antibody Therapeutics Market: Other Non-Cancer Diseases (2019-2024) & ($ Millions)
Figure 16. Global Next Generation Antibody Therapeutics Market Size Market Share by Application in 2023
Figure 17. Global Next Generation Antibody Therapeutics Revenue Market Share by Player in 2023
Figure 18. Global Next Generation Antibody Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Next Generation Antibody Therapeutics Market Size 2019-2024 ($ Millions)
Figure 20. APAC Next Generation Antibody Therapeutics Market Size 2019-2024 ($ Millions)
Figure 21. Europe Next Generation Antibody Therapeutics Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Next Generation Antibody Therapeutics Market Size 2019-2024 ($ Millions)
Figure 23. Americas Next Generation Antibody Therapeutics Value Market Share by Country in 2023
Figure 24. United States Next Generation Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Next Generation Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Next Generation Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Next Generation Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Next Generation Antibody Therapeutics Market Size Market Share by Region in 2023
Figure 29. APAC Next Generation Antibody Therapeutics Market Size Market Share by Type in 2023
Figure 30. APAC Next Generation Antibody Therapeutics Market Size Market Share by Application in 2023
Figure 31. China Next Generation Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Next Generation Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Next Generation Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Next Generation Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Next Generation Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Next Generation Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Next Generation Antibody Therapeutics Market Size Market Share by Country in 2023
Figure 38. Europe Next Generation Antibody Therapeutics Market Size Market Share by Type (2019-2024)
Figure 39. Europe Next Generation Antibody Therapeutics Market Size Market Share by Application (2019-2024)
Figure 40. Germany Next Generation Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Next Generation Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Next Generation Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Next Generation Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Next Generation Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Next Generation Antibody Therapeutics Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Next Generation Antibody Therapeutics Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Next Generation Antibody Therapeutics Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Next Generation Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Next Generation Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Next Generation Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Next Generation Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Next Generation Antibody Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Next Generation Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 54. APAC Next Generation Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 55. Europe Next Generation Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Next Generation Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 57. United States Next Generation Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 58. Canada Next Generation Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Next Generation Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Next Generation Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 61. China Next Generation Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. Japan Next Generation Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. Korea Next Generation Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Next Generation Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. India Next Generation Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. Australia Next Generation Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. Germany Next Generation Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. France Next Generation Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. UK Next Generation Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Italy Next Generation Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Russia Next Generation Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. Spain Next Generation Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Next Generation Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Next Generation Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. Israel Next Generation Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Next Generation Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Next Generation Antibody Therapeutics Market Size 2025-2030 ($ Millions)
Figure 78. Global Next Generation Antibody Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Next Generation Antibody Therapeutics Market Size Market Share Forecast by Application (2025-2030)
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
In-depth database
Our Report’s database covers almost all topics of all regions over the Globe..
Recognised publishing sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales support.
Safe & Secure
Complete secure payment process.
: sales@marketintelligencedata.com
: 1137 waynewood dr,Waxhaw NC 28173 ,United States
: +1 (704) 266-3234
